日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling

NRF2通过调节凋亡信号传导介导黑色素瘤对GCDH的依赖

Sachin Verma, David Crawford, Ali Khateb, Yongmei Feng, Eduard Sergienko, Gaurav Pathria, Chen-Ting Ma, Steven H Olson, David Scott, Rabi Murad, Eytan Ruppin, Michael Jackson, Ze'ev A Ronai

MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction

MAPK 信号调节 c-MYC 使黑色素瘤细胞适应天冬酰胺限制

Gaurav Pathria, Sachin Verma, Jun Yin, David A Scott, Ze'ev A Ronai

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma

IMD-0354 作为黑色素瘤谷氨酰胺载体蛋白抑制剂的鉴定和特性

Yongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, Michael Jackson, Brian James, Jun Yin, David A Scott, Ze'ev A Ronai

Translational reprogramming marks adaptation to asparagine restriction in cancer

翻译重编程标志着癌症对天冬酰胺限制的适应

Gaurav Pathria, Joo Sang Lee #, Erez Hasnis #, Kristofferson Tandoc, David A Scott, Sachin Verma, Yongmei Feng, Lionel Larue, Avinash D Sahu, Ivan Topisirovic, Eytan Ruppin, Ze'ev A Ronai

Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival

通过抑制 LDHA 来靶向瓦堡效应,可启动 ATF4 信号传导,促进癌细胞存活

Gaurav Pathria, David A Scott, Yongmei Feng, Joo Sang Lee, Yu Fujita, Gao Zhang, Avinash D Sahu, Eytan Ruppin, Meenhard Herlyn, Andrei L Osterman, Ze'ev A Ronai

NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo

NVP-LDE225 是一种强效且选择性的 SMOOTHENED 拮抗剂,可在体外和体内抑制黑色素瘤的生长。

Ahmad Jalili ,Kirsten D Mertz, Julia Romanov, Christine Wagner, Frank Kalthoff, Anton Stuetz, Gaurav Pathria, Melanie Gschaider, Georg Stingl, Stephan N Wagner

Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma

细胞周期依赖性蛋白激酶抑制剂 CDKN2C 和 CDKN1A 在人类黑色素瘤中的双重抑制

Ahmad Jalili, Christine Wagner, Mikhail Pashenkov, Gaurav Pathria, Kirsten D Mertz, Hans R Widlund, Mathieu Lupien, Jean-Philippe Brunet, Todd R Golub, Georg Stingl, David E Fisher, Sridhar Ramaswamy, Stephan N Wagner

Polo-like kinase 1 is a potential therapeutic target in human melanoma

Polo 样激酶 1 是人类黑色素瘤的潜在治疗靶点

Ahmad Jalili, Anna Moser, Mikhail Pashenkov, Christine Wagner, Gaurav Pathria, Viola Borgdorff, Melanie Gschaider, Georg Stingl, Sridhar Ramaswamy, Stephan N Wagner